ArticlePloS one2026
Accuracy of sarcopenia screening tools among older adults with stroke undergoing inpatient rehabilitation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Screening on the Paretic Side is Superior for Detecting Possible Sarcopenia in Individuals After Chronic Stroke: Preliminary Findings.Neurology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAppropriate screening tools for sarcopenia are available for older adults with stroke undergoing inpatient rehabilitation, however how well these tools predict and eventually diagnose sarcopenia remain unknown.
objectiveTo investigate the accuracy of five index tools including calf circumference (CC), the strength, assistance with walking, rising from a chair, climbing stairs and falls (SARC-F), the CC combined with SARC-F (SARC-CalF), the 5-item and 7-item Mini Sarcopenia Risk Assessment (MSRA-5 and MSRA-7) for screening sarcopenia among older adults with stroke undergoing inpatient rehabilitation according to the guideline from the Asian Working Group for Sarcopenia 2019.
methodsStroke patients aged sixty years and older who admitted for inpatient rehabilitation were included between April 2023 and June 2024. In this study, sarcopenia was defined by low skeletal muscle mass and low grip strength. Skeletal muscle mass was evaluated using a bioelectrical impedance analysis. Grip strength was assessed using a digital handheld dynamometer. The five index tests were applied. Diagnostic indices and areas under the receiver operating characteristic curves (AUC) were analyzed. Youden's index was used to determine the optimal cut-off values for the index tests.
resultsOne-hundred and fourteen patients with stroke were included (55.26% male) with mean age of 70.39 years. The prevalence of sarcopenia was 50.88%. The AUC with 95% confidence interval of CC, SARC-F, SARC-CalF, MSRA-5 and MSRA-7 were 0.873 (0.797-0.928), 0.653 (0.558-0.740), 0.832 (0.751-0.896), 0.641 (0.546-0.729), and 0.626 (0.530-0.715), respectively. The optimal cut-off points of the CC were < 33 cm for men, and < 32 cm for women, and the optimal cut-off point of SARC-CalF was ≥ 16.
conclusionsThe CC and SARC-CalF were demonstrated appropriate diagnostic performance for screening sarcopenia in older adults with stroke undergoing inpatient rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.